| Author (Corporate) | European Medicines Agency |
|---|---|
| Series Title | News |
| Series Details | 25.10.10 |
| Publication Date | 25/10/2010 |
| Content Type | News |
|
Healthcare institutions from Europe, in October 2010, launched a new pilot process testing multi-stakeholder consultations in early-stage drug development. The purpose of the consultations is to improve clarity and alignment among the stakeholders regarding what constitutes a medicine’s value and the evidence required to demonstrate that value most effectively. |
|
| Source Link | Link to Main Source http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2010/10/news_detail_001138.jsp&mid=WC0b01ac058004d5c1&murl=menus/news_and_events/news_and_events.jsp |
| Subject Categories | Health |
| Countries / Regions | Europe, France, Germany, Italy, Netherlands, Sweden, United Kingdom |
